Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Objective. To evaluate the effectiveness and safety of coenzyme Q10 for patients with type 2 diabetes mellitus (T2DM). Methods. Data from randomized controlled trials were obtained to assess the effects of coenzyme Q10 versus placebo or western medicine on patients with T2DM. The study’s registration number is CRD42018088474. The primary outcomes included glycosylated hemoglobin, fasting blood glucose, and fasting insulin. Result. Thirteen trials involving 765 patients were included. Compared with the control group, coenzyme Q10 may decrease the HbA1c (WMD −0.29; 95% CI −0.54, −0.03; P=0.03) and the fasting blood glucose (WMD −11.21; 95% CI −18.99, −3.43; P=0.005). For fasting insulin, there is also not strong evidence that confirms which one is better because there was no statistical difference (WMD −0.48; 95% CI −2.54, 1.57; P=0.65). Conclusion. Based on current evidence, coenzyme Q10 may assist glycemic control, decrease TG, and improve HDL-C in patients with T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have shown that the intake of exogenous CoQ10 could help to prevent the progression of illness, such as heart failure, metabolic syndrome, NAFLD, diabetes mellitus, and several neurodegenerative diseases177,181–186.”
From Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions (2021) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CoQ10 is an abundant lipid-soluble nutrient scavenging free radical and protecting cells against oxidative damage (Zhang et al., 2018).”
From Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact (2020) · cites this paper as Zhang et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“5 million deaths in 2012 as it relates to increased risk of cardiovascular and other diseases [4, 5].”
BackgroundBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 1×
“Future clinical trials are required to report AEs with more explanations [42].”
BackgroundMortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389 · cited 1×
“5 million deaths in 2012 as it relates to increased risk of cardiovascular and other diseases [4, 5].”
BackgroundHodgson, J., Watts, G., Playford, D., Burke, V, & Croft, K. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601464 · Cited by 252
Román-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz, A. G., & Cardona-Muñoz, E. G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3425617 · Cited by 248 · cited 2×
“[15] found that coenzyme Q10 levels in T2DM patients were significantly lower than those in healthy people, while their MDA levels were significantly Random sequence generation (selection bias)”
BackgroundSimultaneous Detection of Ubiquinol and Ubiquinone in Human Plasma as a Marker of Oxidative Stress
Yamashita, S., & Yamamoto, Y. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2187 · Cited by 219 · cited 1×
“The ubiquinol/ubiquinone ratio is often utilized as an indicator to react to the body’s oxidative stress [38].”
MethodUse of Antioxidant Nutrients in the Prevention and Treatment of Type 2 Diabetes
Ruhe, R. C., & McDonald, R. B. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719169 · Cited by 134 · cited 1×
“T2DM occurs when the organism fails to respond to the increased blood glucose caused by the impaired β cell secretion and/or insulin resistance [1, 8].”
BackgroundPlayford, D. A., Watts, G. F., Croft, K. D., & Burke, V. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00417-3 · Cited by 98
15. Diabetes Advocacy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s015 · Cited by 97 · cited 1×
“At present, the treatment of diabetes is still lacking etiological treatment; the treatment of diabetes is mainly achieved through diabetes management including healthy eating, weight control, appropriate physical activity, antiglycemic medications, and multifactorial risk reduction [7].”
BackgroundAlam, M. A., & Rahman, M. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-60 · Cited by 91 · cited 1×
“Therefore, exogenous coenzyme Q10 supplements may improve the oxidative stressinduced abnormalities in mitochondrial functions, thereby bettering glycemic control in patients with T2DM [20].”
BackgroundAmin, M. M., Asaad, G. F., Abdel Salam, R. M., El-Abhar, H. S., & Arbid, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089169 · Cited by 82 · cited 1×
“coenzyme Q10 level is beneficial for this cycle [40].”
BackgroundEriksson, J. G., Forsén, T. J., Mortensen, S. A., & Rohde, M. (1999) · BioFactors · doi:10.1002/biof.5520090229 · Cited by 79
Suksomboon, N., Poolsup, N., & Juanak, N. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12280 · Cited by 77
Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early Diabetic Kidney Disease
Daehn, I. S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00076 · Cited by 77 · cited 1×
“Recent studies have found that T2DM patients have significantly lower levels of coenzyme Q10 than healthy people [1, 14–16], which indicates that coenzyme Q10 deficiency may reduce the organism’s ability to counter hyperglycemiainduced oxidative stress in T2DM [17, 18].”
BackgroundChew, G. T., Watts, G. F., Davis, T. M. E., Stuckey, B. G. A., Beilin, L. J., Thompson, P. L., Burke, V., & Currie, P. J. (2008) · Diabetes Care · doi:10.2337/dc08-0118 · Cited by 72 · cited 1×
“’s research [27], there were two trial groups and two control groups.”
BackgroundSecondary Coenzyme Q 10 Deficiencies in Oxidative Phosphorylation (OXPHOS) and Non-OXPHOS Disorders
Yubero, D., Montero, R., Martín, M. A., Montoya, J., Ribes, A., Grazina, M., Trevisson, E., Rodriguez-Aguilera, J. C., Hargreaves, I. P., Salviati, L., et al. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.06.007 · Cited by 72
Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment.
Lamson, D. W., & Plaza, S. M. (2002) · PubMed · Cited by 70
Obesity‐induced mitochondrial dysfunction in porcine adipose tissue‐derived mesenchymal stem cells
Meng, Y., Eirin, A., Zhu, X., Tang, H. R., Chanana, P., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26402 · Cited by 69 · cited 1×
“An increasing number of studies have shown that in obese and T2DM patients, reactive oxygen species can aggravate the insulin resistance status and interfere with the insulin signaling pathway through impairing the mitochondrial ability to oxidize fat [12, 13].”
BackgroundZahedi, H., Eghtesadi, S., Seifirad, S., Rezaee, N., Shidfar, F., Heydari, I., Golestan, B., & Jazayeri, S. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-014-0081-6 · Cited by 67
Brøns, C., Jacobsen, S., Hiscock, N., White, A., Nilsson, E., Dunger, D., Astrup, A., Quistorff, B., & Vaag, A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2011 · Cited by 65 · cited 1×
“An increasing number of studies have shown that in obese and T2DM patients, reactive oxygen species can aggravate the insulin resistance status and interfere with the insulin signaling pathway through impairing the mitochondrial ability to oxidize fat [12, 13].”
BackgroundEndocrine Disorders in Primary Mitochondrial Disease
Al-Gadi, I., Haas, R., Falk, M. J., Goldstein, A. C., & McCormack, S. E. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00434 · Cited by 65 · cited 1×
“Oxidative stress and insulin resistance are recognized pathogenic mechanisms in the development and progression of T2DM and its complications [1, 9].”
BackgroundSupplementation of Coenzyme Q10 among Patients with Type 2 Diabetes Mellitus
Shen, Q., & Pierce, J. (2015) · Healthcare · doi:10.3390/healthcare3020296 · Cited by 57 · cited 4×
“Persistent hyperglycemia will lead to the overproduction of reactive oxygen species, which can cause oxidative damage to deoxyribonucleic acid (DNA), proteins, and lipids [1, 10, 11].”
BackgroundInfluentialYagihashi, S., Inaba, W., & Mizukami, H. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12424 · Cited by 51 · cited 2×
“Persistent hyperglycemia will lead to the overproduction of reactive oxygen species, which can cause oxidative damage to deoxyribonucleic acid (DNA), proteins, and lipids [1, 10, 11].”
BackgroundAkbari Fakhrabadi, M., Zeinali Ghotrom, A., Mozaffari-Khosravi, H., Hadi Nodoushan, H., & Nadjarzadeh, A. (2014) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000211 · Cited by 47
Chatziralli, I., THEODOSSIADIS, G. P., Dimitriadis, P., Charalambidis, M., Αγοραστός, Α., Migkos, Z., Platogiannis, N., Moschos, M. M., THEODOSSIADIS, P. G., & Keryttopoulos, P. (2017) · The Open Ophthalmology Journal · doi:10.2174/1874364101711010051 · Cited by 45
Lim, S. C., Lekshminarayanan, R., Goh, S. K., Ong, Y. Y., Subramaniam, T., Sum, C. F., Ong, C. N., & Lee, B. L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.012 · Cited by 44 · cited 1×
“One RCT [33] used block randomization, three RCTs [34, 36, 37] utilized permuted random block allocation, and one RCT used a website [35] to conduct randomization; we therefore rated them as having a low risk of bias.”
MethodMezawa, M., Takemoto, M., Onishi, S., Ishibashi, R., Ishikawa, T., Yamaga, M., Fujimoto, M., Okabe, E., He, P., Kobayashi, K., et al. (2012) · BioFactors · doi:10.1002/biof.1038 · Cited by 42
Mehrdadi, P., Kolahdouz Mohammadi, R., Alipoor, E., Eshraghian, M., Esteghamati, A., & Hosseinzadeh-Attar, M. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-110570 · Cited by 40 · cited 1×
“One RCT [33] used block randomization, three RCTs [34, 36, 37] utilized permuted random block allocation, and one RCT used a website [35] to conduct randomization; we therefore rated them as having a low risk of bias.”
MethodHasegawa, G., Yamamoto, Y., Zhi, J., Tanino, Y., Yamasaki, M., Yano, M., Nakajima, T., Fukui, M., Yoshikawa, T., & Nakamura, N. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0199-6 · Cited by 39 · cited 1×
“Furthermore, the ubiquinone/ubiquinol ratio in T2DM patients was continuously higher than that in normal heathy people throughout the day after breakfast, which indicates that postprandial hyperglycemia is associated with increased oxidative stress [16].”
BackgroundEffect of coenzyme Q10 on glycaemic control, oxidative stress and adiponectin in type 2 diabetes.
Moazen, M., Mazloom, Z., Ahmadi, A., Dabbaghmanesh, M. H., & Roosta, S. (2015) · PubMed · Cited by 37
The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients.
Kolahdouz‐Mohammadi, R., Hosseinzadeh‐Attar, M. J., Eshraghian, M. R., Nakhjavani, M., Khorami, E., & Esteghamati, A. (2013) · PubMed · Cited by 36
Moradi, M., Haghighatdoost, F., Feizi, A., Larijani, B. A., & Azadbakht, L. (2016) · PubMed · Cited by 33
Gholami, M., Rezvanfar, M. R., Delavar, M., Abdollahi, M., & Khosrowbeygi, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-124183 · Cited by 30
Hosseinzadeh‐Attar, M. J., Kolahdouz‐Mohammadi, R., Eshraghian, M. R., Nakhjavani, M., Khorrami, E., Ebadi, M., & Esteghamati, A. (2015) · PubMed · Cited by 29
Role of L-carnitine and Coenzyme Q10 as Adjuvant Therapy in Patients with Type 2 Diabetes Mellitus
Mohammed-Jawad, N. K., & Al-Sabbagh, M. S. (2014) · American journal of pharmacological sciences · doi:10.12691/ajps-2-5-2 · Cited by 24
Research works printed but not linked: 9
- 2002, Alternative Medicine Review, 7, 94
- 2016, Archives of Iranian Medicine, 19, 588
- 2011, Chapter 16: special topics in statistics
- 2011, Chapter 8: assessing risk of bias in included studies
- 2011, Chapter 9: analyzing data and undertaking meta-analyses
- 2015, The Journal of the Pakistan Medical Association, 65, 404
- 2015, Minerva Endocrinologica, 40, 259
- 2013, Minerva Gastroenterologica e Dietologica, 59, 231
- 2011, Chapter 14: adverse effects
Cited by
da Silveira, W. A., Fazelinia, H., Rosenthal, S. B., Laiakis, E. C., Kim, M. S., Meydan, C., Kidane, Y., Rathi, K. S., Smith, S. M., Stear, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.002 · Cited by 402
“CoQ10 is an abundant lipid-soluble nutrient scavenging free radical and protecting cells against oxidative damage (Zhang et al., 2018).”
Metabolic and Vascular Effect of the Mediterranean Diet
Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., & Pinto, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194716 · Cited by 269
“[157] conducted a study that evaluated endothelial function in healthy patients with high lipid levels who practiced a Mediterranean diet.”
An integrative collaborative care model for people with mental illness and physical comorbidities
Ee, C., Lake, J., Firth, J., Hargraves, F., de Manincor, M., Meade, T., Marx, W., & Sarris, J. J. (2020) · International Journal of Mental Health Systems · doi:10.1186/s13033-020-00410-6 · Cited by 194
Disorders of Human Coenzyme Q10 Metabolism: An Overview
Hargreaves, I., Heaton, R. A., & Mantle, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186695 · Cited by 182
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M., Carvalho, A. F., Bortolasci, C. C., Walder, K., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 113
Metadata
- Authors
- Zhang, S.-Y., Yang, K.-L., Zeng, L.-T., Wu, X.-H., & Huang, H.-Y.
- Affiliations
- Hunan University of Chinese Medicine, Changsha 410208, China
- Jiangxi Provincial People’s Hospital, Nanchang 330006, China
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2018-09-16
- Volume
- 2018
- Pages
- 1-11
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC6165589
- OpenAlex
- W2890146747
- Cited by
- 51
- References
- 35
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 5 · 2023: 6 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 5 · 2018: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81373551, 20134323110001, S2014S2032)
- Ministry of Education of the People’s Republic of China (81373551, 20134323110001, S2014S2032)
- Hunan Provincial Science and Technology Department (81373551, 20134323110001, S2014S2032)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- coenzyme Q10, type 2 diabetes, glycemic control, HbA1c, fasting blood glucose, fasting insulin, lipid profile, HDL cholesterol, triglycerides, dietary supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.